tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Vitiligo D014820 2 associated lipids
Hemophilia B D002836 3 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Hyperkalemia D006947 3 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Pemphigus, Benign Familial D016506 3 associated lipids
Skin Diseases, Vesiculobullous D012872 5 associated lipids
Prurigo D011536 4 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Cryptococcosis D003453 3 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Simian Acquired Immunodeficiency Syndrome D016097 4 associated lipids
Castleman Disease D005871 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Toxocariasis D014120 3 associated lipids
Fistula D005402 8 associated lipids
Confusion D003221 4 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Viremia D014766 4 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Parotitis D010309 4 associated lipids
Tuberous Sclerosis D014402 2 associated lipids
Ocular Motility Disorders D015835 2 associated lipids
Pain, Intractable D010148 4 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Perceptual Disorders D010468 3 associated lipids
Polyneuropathies D011115 3 associated lipids
Heart Injuries D006335 6 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Exanthema D005076 11 associated lipids
Bronchiolitis D001988 6 associated lipids
Reflex Sympathetic Dystrophy D012019 4 associated lipids
Kartagener Syndrome D007619 2 associated lipids
Earache D004433 2 associated lipids
Delayed Graft Function D051799 2 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Intussusception D007443 1 associated lipids
Neoplasms, Second Primary D016609 4 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Apraxias D001072 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Venous Insufficiency D014689 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Li H et al. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. 2015 J. Med. Microbiol. pmid:25355935
Gallon L et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. 2015 Kidney Int. pmid:25354238
Pamuk F et al. Evaluation of gingival alterations in rats medicated with cyclosporine A, tacrolimus and sirolimus: a stereological study. 2015 J. Periodont. Res. pmid:25399832
Koreth J et al. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. 2015 Biol. Blood Marrow Transplant. pmid:26055298
Sikma MA et al. Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. 2015 Am. J. Transplant. pmid:26053114
Rozman Peterka T et al. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation. 2015 J Pharm Biomed Anal pmid:25804434
Revollo J Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2015 Drug Des Devel Ther pmid:26005334
Cortes X et al. Successful use of infliximab and tacrolimus in a patient with Crohn's disease. 2015 Int J Clin Pharmacol Ther pmid:25997551
Takahashi N et al. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. 2015 Rheumatol. Int. pmid:25991396
Brännström M et al. Livebirth after uterus transplantation. 2015 Lancet pmid:25301505
de Weerd AE et al. ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption. 2015 Transpl. Int. pmid:25070762
Yahng SA et al. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia. 2015 Biol. Blood Marrow Transplant. pmid:25300871
Cheng S and Rodier F Manipulating senescence in health and disease: emerging tools. 2015 Cell Cycle pmid:25928330
Hricik DE et al. Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. 2015 J. Am. Soc. Nephrol. pmid:25925687
Matas AJ and Gaston RS Moving Beyond Minimization Trials in Kidney Transplantation. 2015 J. Am. Soc. Nephrol. pmid:25925686
Bogéa TH et al. Light Induces Ultrastructural Changes in Rod Outer and Inner Segments, Including Autophagy, in a Transgenic Xenopus laevis P23H Rhodopsin Model of Retinitis Pigmentosa. 2015 Invest. Ophthalmol. Vis. Sci. pmid:26720441
Hiraoka S et al. The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients. 2015 BMC Gastroenterol pmid:25925267
Falloon K et al. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus. 2015 PLoS ONE pmid:26366742
Chapron B et al. Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. 2015 J Pharm Pharm Sci pmid:25877445
Nashan B et al. Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. 2015 Trials pmid:25873064
Ramachandran R et al. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease. 2015 Nephrology (Carlton) pmid:25872662
Shahraki M et al. Influence of Tacrolimus (FK506) on Nerve Regeneration Using Allografts: A Rat Sciatic Nerve Model. 2015 J. Oral Maxillofac. Surg. pmid:25869987
Zhu L et al. Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. 2015 Xenobiotica pmid:25869250
Dastgheib L et al. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial. 2015 J Dermatolog Treat pmid:24552352
Rodríguez-Rodríguez AE et al. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus. 2015 Nefrologia pmid:26299169
Hlavaty KA et al. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 2015 Clin. Immunol. pmid:25805659
Halvorsen JA and Aasebø W Oral tacrolimus treatment of pruritus in prurigo nodularis. 2015 Acta Derm. Venereol. pmid:25804254
Sigurgeirsson B et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. 2015 Pediatrics pmid:25802354
Garritsen FM et al. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. 2015 J Eur Acad Dermatol Venereol pmid:25752497
Wu D et al. BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen. 2015 Exp Clin Transplant pmid:25748726
Jo GA et al. Isolation and characterization of a 17-kDa FKBP-type peptidyl-prolyl cis/trans isomerase from Vibrio anguillarum. 2015 Protein Expr. Purif. pmid:25747528
Tachibana T et al. Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure. 2015 Intern. Med. pmid:26521905
Liu J et al. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods. 2015 Clin Ther pmid:26519232
Guerra Júnior AA et al. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil. 2015 Rev Saude Publica pmid:25741648
Shuker N et al. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. 2015 Transplant Rev (Orlando) pmid:25687818
Kawakami K et al. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. 2015 World J. Gastroenterol. pmid:25684955
Al Gain M et al. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus]. 2015 Ann Dermatol Venereol pmid:25683011
Ikeya K et al. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. 2015 Dig Liver Dis pmid:25682993
Zhao L et al. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. 2015 Int J Pharm pmid:25681723
Matsushima M et al. [A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome]. 2015 Rinsho Shinkeigaku pmid:26458569
Kim S et al. Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant. 2015 Neurobiol. Aging pmid:26455952
Fukuta T et al. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. 2015 Eur J Pharm Biopharm pmid:26455340
Buendía JA et al. Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients. 2015 Exp Clin Transplant pmid:26450467
Cuellar-Rodriguez J et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. 2015 Biol. Blood Marrow Transplant. pmid:25636378
Schoettler M et al. Treatment and outcomes of immune cytopenias following solid organ transplant in children. 2015 Pediatr Blood Cancer pmid:25308853
Chung H et al. Renal transplantation: better fat than thin. 2015 J. Surg. Res. pmid:25634827
Pennington CA and Park JM Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. 2015 Am J Health Syst Pharm pmid:25631834
Mok CC Mycophenolate mofetil for lupus nephritis: an update. 2015 Expert Rev Clin Immunol pmid:26364748
Satake K et al. Olopatadine hydrochloride suppresses hot flashes induced by topical treatment with tacrolimus ointment in rats. 2015 Eur. J. Pharmacol. pmid:26362749
Gao L and Sun Y In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. 2015 Antimicrob. Agents Chemother. pmid:26303797
Iwamoto T et al. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation. 2015 Ther Drug Monit pmid:25565672
Yao X et al. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase. 2015 Ther Drug Monit pmid:25565669
Nelson R et al. Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience. 2015 Bone Marrow Transplant. pmid:26301969
Lemaitre F et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. 2015 Clin. Biochem. pmid:25562187
Tedesco-Silva H et al. Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. 2015 Am. J. Transplant. pmid:25988935
Bauters T et al. Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. 2015 J Oncol Pharm Pract pmid:24748582
Tornatore KM et al. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients. 2015 Clin Pharmacokinet pmid:25511793
Li JL et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. 2015 Pharmacogenomics pmid:26228923
Zhu LQ et al. Posterior reversible encephalopathy syndrome and graft-versus-host disease after liver transplantation: a case report and review of the literature. 2015 Int J Clin Pharmacol Ther pmid:26227100
Lu YX et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. 2015 Acta Pharmacol. Sin. pmid:25500866
Zhang JJ et al. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. 2015 Int J Clin Pharmacol Ther pmid:26227094
Jung JW et al. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease. 2015 Am. J. Ophthalmol. pmid:25498356
Roberts WK et al. A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. 2015 Ann. Neurol. pmid:26224283
Kloster-Jensen K et al. Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro. 2015 Transpl. Int. pmid:26046470
Peake RW et al. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. 2015 Ther Drug Monit pmid:25072947
Mettang T and Kremer AE Uremic pruritus. 2015 Kidney Int. pmid:24402092
Lancia P et al. Choosing the right dose of tacrolimus. 2015 Arch. Dis. Child. pmid:25416736
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Chen CH et al. Comparison of tuberculosis infection rates in a national database of renal transplant patients with data from a single center in Taiwan. 2014 Transplant. Proc. pmid:24656019
Furian L et al. Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors. 2014 Transplant. Proc. pmid:25498057
Ciancio G et al. Randomized trial of three induction antibodies in kidney transplantation: long-term results. 2014 Transplantation pmid:24477186
Pedroso JA et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. 2014 Transplant. Proc. pmid:25242789
Torres IB et al. The Interplay between inflammation and fibrosis in kidney transplantation. 2014 Biomed Res Int pmid:24991565
Yargui L et al. Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in Algiers Mustapha Hospital. 2014 Saudi J Kidney Dis Transpl pmid:24434409
Guitard J et al. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. 2014 Clin. Nephrol. pmid:24040781
Baldo A et al. Vitiligo, NB-UVB and tacrolimus: our experience in Naples. 2014 G Ital Dermatol Venereol pmid:24566573
Favennec C et al. Consideration of the switch from twice-daily to once-daily tacrolimus in pediatric kidney transplant in daily clinical practice: pharmacokinetic parameters, patient satisfaction and medical practices. 2014 Pediatr Transplant pmid:25164065
Giordanetto F and Kihlberg J Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? 2014 J. Med. Chem. pmid:24044773
Murota H et al. Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model. 2014 Acta Derm. Venereol. pmid:23817562
Gupta AK et al. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. 2014 PLoS ONE pmid:24819773
Amanova A et al. Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. 2014 Clin Transplant pmid:25125128
Schmid S et al. Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. 2014 Ann. Transplant. pmid:25123847
Guillén-Gómez E et al. Monocyte implication in renal allograft dysfunction. 2014 Clin. Exp. Immunol. pmid:24134783
Farkas K et al. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. 2014 Expert Rev Gastroenterol Hepatol pmid:24738535
Li T et al. Effect of FK506 nanospheres on regeneration of allogeneic nerve after transplant. 2014 Asian Pac J Trop Med pmid:25066398
Miyauchi T et al. Evidence for the therapeutic efficacy of either mild hypothermia or oxygen radical scavengers after repetitive mild traumatic brain injury. 2014 J. Neurotrauma pmid:24341607
Garriga-Companys S and Labrador-Horrillo M [Chronic spontaneous urticaria]. 2014 Med Clin (Barc) pmid:24120109
Inaba A et al. Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid. 2014 Rinsho Ketsueki pmid:24850458
Kurzawski M et al. Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. 2014 Pharmacogenet. Genomics pmid:24921414
Parvizi Z et al. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation. 2014 Mol. Biol. Rep. pmid:24996284
Ji SM et al. Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. 2014 Transplant. Proc. pmid:25498056
Hebral AL et al. Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. 2014 Nephrol. Dial. Transplant. pmid:24914091
Hayes D et al. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. 2014 Pediatr. Neurol. pmid:24405697
Bergmann TK et al. Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients. 2014 Clin Drug Investig pmid:24385281
Lesche D et al. CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. 2014 Ther Drug Monit pmid:24739669
van der Vusse ML et al. Helicobacter canis bacteremia in a renal transplant patient. 2014 Transpl Infect Dis pmid:24372779
Földes G et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. 2014 Stem Cells Dev. pmid:24192059